---
figid: PMC7274521__DDDT-14-2079-g0006
figtitle: Schematic description of resveratrol-mediated suppression of inflammation
  in IL-1Beta-induced SW1353 cells
organisms:
- Mus musculus
- Rattus norvegicus
- Armoracia rusticana
- Arachis hypogaea
- Homo sapiens
- Opsanus beta
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC7274521
filename: DDDT-14-2079-g0006.jpg
figlink: pmc/articles/PMC7274521/figure/F0006/
number: F6
caption: Schematic description of resveratrol-mediated suppression of inflammation
  in IL-1β-induced SW1353 cells. IL-1β-upregulated TLR4 expression results in the
  activation of the TLR4/NF-кB signaling via MyD88-dependent and -independent pathways,
  which causes translocation of NF-кB into the nucleus resulting in the production
  of pro-inflammatory cytokines such as IL-6, MMP13, TNFα, etc. The activation of
  TLR4 by IL-1β can induce PI3K/Akt phosphorylation, which increases the phosphorylation
  of FoxO1 and inactivates it. Inactivated FoxO1 reduces the expression of TLR4, establishing
  a self-limiting mechanism of inflammation. Resveratrol treatment can upregulate
  PI3K/Akt phosphorylation and inactivate FoxO1, that is resveratrol highlights the
  self-limiting mechanism by promoting PI3K/Akt activation, thereby down-regulating
  TLR4/NF-кB pathway and inflammation. ➞, lead to/activate; ⊣, inhibit.
papertitle: Resveratrol Exerts Anti-Osteoarthritic Effect by Inhibiting TLR4/NF-κB
  Signaling Pathway via the TLR4/Akt/FoxO1 Axis in IL-1β-Stimulated SW1353 Cells.
reftext: Xiaolei Xu, et al. Drug Des Devel Ther. 2020;14:2079-2090.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9466362
figid_alias: PMC7274521__F6
figtype: Figure
redirect_from: /figures/PMC7274521__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7274521__DDDT-14-2079-g0006.html
  '@type': Dataset
  description: Schematic description of resveratrol-mediated suppression of inflammation
    in IL-1β-induced SW1353 cells. IL-1β-upregulated TLR4 expression results in the
    activation of the TLR4/NF-кB signaling via MyD88-dependent and -independent pathways,
    which causes translocation of NF-кB into the nucleus resulting in the production
    of pro-inflammatory cytokines such as IL-6, MMP13, TNFα, etc. The activation of
    TLR4 by IL-1β can induce PI3K/Akt phosphorylation, which increases the phosphorylation
    of FoxO1 and inactivates it. Inactivated FoxO1 reduces the expression of TLR4,
    establishing a self-limiting mechanism of inflammation. Resveratrol treatment
    can upregulate PI3K/Akt phosphorylation and inactivate FoxO1, that is resveratrol
    highlights the self-limiting mechanism by promoting PI3K/Akt activation, thereby
    down-regulating TLR4/NF-кB pathway and inflammation. ➞, lead to/activate; ⊣, inhibit.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Il16
  - Tlr4
  - Rnf138
  - Myd88
  - Akt1
  - Pik3cg
  - Nfkb1
  - Il6
  - Tnf
  - Mmp13
  - IL16
  - TLR4
  - TRIM69
  - TICAM1
  - MYD88
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NFKB1
  - IL6
  - TNF
  - MMP13
  - SPP1
  - Trim69
  - Ticam1
  - Ticam2
  - Pik3r1
  - Spp1
  - Toll-4
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dif
  - dl
  - Rel
  - et
  - egr
  - il16
  - ticam1
  - myd88
  - il6
  - tnfb
  - mmp13a
  - Resveratrol
---
